North America Dystonia Drug Market Supported by Expanding Neurology...

added blog Other

2026-08-05 14:55:25

North America Dystonia Drug Market Supported by Expanding Neurology Research and Drug Innovation

North America holds a significant share of the Dystonia Drug Market, driven by its advanced healthcare infrastructure, strong neurological research ecosystem, and widespread availability of specialized treatment centers. The United States and Canada continue to invest heavily in neuroscience research, rare disease programs, and innovative pharmaceutical development, creating a favorable...

0 Comments 0 Shares 52 Views 0 Reviews